STRAHILEVITZ MEIR has a total of 18 patent applications. Its first patent ever was published in 1977. It filed its patents most often in United States, EPO (European Patent Office) and WIPO (World Intellectual Property Organization). Its main competitors in its focus markets pharmaceuticals, medical technology and biotechnology are INTERFERON SCIENCES INC, H K MULFORD COMPANY and AMYLEX PHARMACEUTICALS INC.
# | Country | Total Patents | |
---|---|---|---|
#1 | United States | 8 | |
#2 | EPO (European Patent Office) | 3 | |
#3 | WIPO (World Intellectual Property Organization) | 3 | |
#4 | Australia | 2 | |
#5 | Canada | 1 | |
#6 | Israel | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Medical technology | |
#3 | Biotechnology | |
#4 | Measurement | |
#5 | Chemical engineering | |
#6 | Machines | |
#7 | Micro-structure and nano-technology |
# | Technology | |
---|---|---|
#1 | Medical preparations | |
#2 | Syringes | |
#3 | Peptides | |
#4 | Analysing materials | |
#5 | Microorganisms | |
#6 | Unspecified technologies | |
#7 | Separation | |
#8 | Nanostructure applications | |
#9 | Therapeutic chemical compounds |
# | Name | Total Patents |
---|---|---|
#1 | Strahilevitz Meir | 17 |
Publication | Filing date | Title |
---|---|---|
US2005265926A1 | Methods and reagents for improving localization of treatment and visualization ligands to sites in a mammal | |
AU2003234194A1 | Methods and devices for targeting a site in a mammal and for removing species from a mammal | |
US7166295B1 | Methods of treatment and diagnostic visualization, particularly in cancer | |
IL110382D0 | Extracorporeal affinity adsorption device | |
US4375414A | Immunological methods for removing species from the blood circulatory system and devices therefor |